Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Ultragenyx Pharmaceutical

Founders Emil D. Kakkis

Overview

Investments

Unlock datapoints

Portfolio analytics

Team

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 2
Average round size
info
The average size of a deal this fund participated in
$27M
Portfolio companies 2
Rounds per year 0.14
Lead investments 1
Exits 1
Key employees Soon

Areas of investment

  • Genetics
  • Biotechnology
  • Health Care
  • Medical
  • Therapeutics

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Ultragenyx Pharmaceutical:
Typical Co-investors
Ultragenyx Pharmaceutical is more likely to invest in rounds together with the following funds:
There are no funds here. If we find new data, we will add it here.
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Ultragenyx Pharmaceutical:
There are no funds here. If we find new data, we will add it here.

Look at other 50 related and similar funds Collapse list
Fund NameLocation
176.com China, Fuzhou, Jiangxi
A3 Angels Lausanne, Switzerland, Vaud
Australian Ethical Investment Australia, New South Wales, Sydney
BioHealth Innovation Maryland, Rockville, United States
Boise Angel Alliance Boise, Idaho, United States
Dotzero Ventures Karachi, Pakistan, Sindh
Futurpreneur Canada, Ontario, Toronto
GAWA Capital Community of Madrid, Madrid, Spain
Georgian Angel Network Detroit, Michigan, United States
Laxus Technologies Chiyoda, Japan
New World CyberBase China, Hong Kong, Hong Kong Island
Richinfo Technology China, Guangdong, Tianjin
Shanghai Shenhu Tonghai Guquan Touzi Jijin Guanli Youxian Gongsi China, Shanghai
Silverman Group Basking Ridge, New Jersey, United States
Southeast Asian fund -
Syncapse Canada, Ontario, Toronto
Trans Pacific Partners California, San Jose, United States
Two Shields Investments England, United Kingdom, Wandsworth
Weiruan Yun Fuhuaqi China, Fujian, Hunan

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Amlogenyx

Biotechnology
Genetics
Therapeutics
$14M02 Aug 2024 -

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Ultragenyx Pharmaceutical?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 2
Average round size 27M
Rounds per year 0.14
Peak activity year 2020
Lead investments 1
Exits 1
Group Appearance index 0.50

Latest deals

CompanyIndustryRound SizeDateInvestorsLocation

Amlogenyx

Biotechnology
Genetics
Therapeutics
$14M02 Aug 2024 -
Crunchbase icon

Content report

The following text will be sent to our editors: